Omnes Capital's investments

Sector 
Industry
Entry Date 
2018
Business 
Co-Investment

World’s largest independent bottler of soft drinks
Headquartered in Netherlands, the company is the global leading independent bottler of soft drinks for retailers and brands focused on Europe and with a presence in the US. It offers the broadest spectrum of products and packaging, and has more than 60 facilities around the world.
Entry Date 
2018
Business 
Venture Capital

Pherecydes Pharma

Specializes in research into innovative and adaptive solutions to fight multi-resistant bacterial infections

Pherecydes Pharma SA specializes in research into innovative and adaptive solutions to fight multi-resistant bacterial infections, using cocktails of natural phages.  
Thanks to its unique expertise, Pherecydes Pharma has managed to develop a large bank of bacteriophages cocktails to fight antibiotic-resistant infections, steadily on the rise since the 1980s.

Sector 
Healthcare facilities
Entry Date 
2017
Business 
Co-Investment

Leading European provider of services to the dependent and the elderly
Headquartered in France, the company is one of the European leading provider of services to the dependent and the elderly, with more than 30,000 beds.
Sector 
Industry
Entry Date 
2017
Business 
Co-Investment

World leader in the design, engineering and production of high-end audio mixing consoles for professional end-users
Headquartered in the United-Kingdom, the company designs and manufactures an expanding range of audio mixing consoles and ancillary products for professional end-users across a variety of applications. With more than a hundred of employees, it has an outstanding reputation for innovation, best-in-class performance and reliability in demanding live productions.
Sector 
Industry
Entry Date 
2017
Business 
Co-Investment

European market leader for premium temporary space solutions
Headquartered in Germany, the company provides temporary and modular building solutions for the industrial sector, special events and large missions requiring rapid deployment systems.
Sector 
Pharma
Entry Date 
2017
Business 
Venture Capital

Octimet

Development of a clinically de-risked MET kinase inhibitor for the treatment of cancers

Founded in 2016, Octimet Oncology N.V. (Belgium) is a new company (spin-off from Johnson & Johnson) that acts as a translational accelerator, focusing on creating value for investors and patients by providing rapid clinical proof of concept for cancer therapies through innovative clinical development strategies and patient centered biomarker approaches. The current focus is on its clinical stage asset OMO-1, a highly selective small molecule MET inhibitor that will be developed with specific biomarkers, whilst an additional late pre-clinical stage oncology asset 0MO-2 will also enter the portfolio.

Sector 
Business services
Entry Date 
2016
Business 
Co-Investment

Global leading software editor for the simulation of sheet metal forming in the automotive industry
Headquartered in Switzerland, the company is the reference software editor for the simulation of sheet metal forming processes to the automotive industry.
Sector 
Pharma
Entry Date 
2016
Business 
Co-Investment

French pharmaceutical company specialized in complex generics
Headquartered in France with a global footprint, the company is specialised in the manufacturing and distribution of products with challenging formulations.
Sector 
Web
Entry Date 
2016
Business 
Co-Investment

Global provider of web content management
Headquartered in Denmark , the company is a global software company with a strong footprint in the web content and customer experience management.
Sector 
Business services
Entry Date 
2014
Business 
Co-Investment

Leading environmental service provider in the Nordics
Headquartered in Finland, the company is a leading provider of business services in Sweden and Finland. With more than 650 employees and 33 facilities, the group provides three complementary services: industrial cleaning, demolition and waste treatment.

Pages

NewsRoom
Press release
17 January 2018
VSORA closes series A financing with investment from
Omnes Capital, Partech Ventures, Angel Investors

Set to Launch Game-Changing Multicore DSP IP to Power 5G Wireless Networks

VSORA closes series A financing with investment from Omnes Capital, Partech Ventures, Angel Investors Set to Launch Game-Changing Multicore DSP IP to Power 5G Wireless Networks
Press release
16 January 2018
Batiweb Group announces buyout of Clien’tel.
The trading name “Le Bon Artisan” is to become “e-travaux”.

Batiweb Group announces buyout of Clien’tel. The trading name “Le Bon Artisan” is to become “e-travaux”.
Publication
Omnes Newsletter no 32: VC news H2 2017
Press release
05 January 2018
Enterome raises €32 million ($38.5 million) in a Series D financing
Enterome raises €32 million ($38.5 million) in a Series D financing
Press release
04 January 2018
Themis Raises EUR 10 Million in Series C Financing to Advance Clinical
Pipeline
Themis Raises EUR 10 Million in Series C Financing to Advance Clinical Pipeline
Press release
22 December 2017
ENGIE and Crédit Agricole Assurances increase their investments
in on-shore wind and solar power in France

ENGIE and Crédit Agricole Assurances increase their investments in on-shore wind and solar power in France

Pages